Tianjin Ringpu Bio-technology Co., Ltd.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100000TV1
CNY
17.63
-0.82 (-4.44%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Net Sales
836.74
885.97
815.78
1,313.55
824.89
732.06
533.20
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
836.74
885.97
815.78
1,313.55
824.89
732.06
533.20
Raw Material Cost
486.49
532.88
509.28
936.97
470.85
452.63
297.48
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
8.85
9.18
9.18
9.50
8.92
7.27
6.35
Selling and Distribution Expenses
186.87
173.55
151.75
214.64
184.17
156.23
103.94
Other Expenses
4.41
3.77
2.95
4.46
4.28
3.06
2.44
Total Expenditure (Excl Depreciation)
726.36
753.28
699.75
1,205.69
706.70
646.69
432.16
Operating Profit (PBDIT) excl Other Income
110.39999999999999
132.7
116
107.89999999999999
118.2
85.39999999999999
101
Other Income
29.09
39.71
3.67
19.69
4.03
10.34
4.41
Operating Profit (PBDIT)
134.11
220.30
176.14
163.13
116.74
135.43
146.36
Interest
8.85
9.18
9.18
9.50
8.92
7.27
6.35
Exceptional Items
1.20
17.95
25.33
-34.19
8.59
4.71
10.18
Gross Profit (PBDT)
350.25
353.09
306.50
376.58
354.04
279.44
235.72
Depreciation
0.00
56.06
56.06
55.81
0.00
47.03
45.03
Profit Before Tax
126.46
173.01
136.22
63.63
116.42
85.85
105.17
Tax
10.27
24.12
15.33
0.35
17.83
9.30
11.57
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
105.78
140.54
115.98
55.99
85.99
72.48
87.57
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
105.78
140.54
115.98
55.99
85.99
72.48
87.57
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
12.94
11.42
4.12
9.67
12.51
5.67
5.93
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
118.73
151.96
120.10
65.65
98.50
78.15
93.50
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
4,673.16
4,561.89
4,565.98
4,469.99
4,549.88
4,463.68
4,570.43
Earnings per share (EPS)
0.23
0.31
0.25
0.12
0.19
0.16
0.19
Diluted Earnings per share
0.23
0.31
0.25
0.12
0.19
0.16
0.19
Operating Profit Margin (Excl OI)
12.55%
14.06%
14.27%
6.67%
13.66%
10.66%
18.18%
Gross Profit Margin
15.11%
25.86%
23.57%
9.09%
14.11%
18.15%
28.17%
PAT Margin
12.64%
15.86%
14.22%
4.26%
10.42%
9.9%
16.42%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Sep 2025 is -5.56% vs 8.61% in Jun 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Sep 2025 is -21.91% vs 26.56% in Jun 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Sep 2025 is -41.86% vs 4.70% in Jun 2025

stock-summary

Interest

QoQ Growth in quarter ended Sep 2025 is -3.26% vs 0.00% in Jun 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025

Compare Quarterly Results Of Tianjin Ringpu Bio-technology Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
836.74
0
836.74
Other Operating Income
0.00
0.00
0.00
Total Operating income
836.74
0
836.74
Raw Material Cost
486.49
0
486.49
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
8.85
0
8.85
Selling and Distribution Expenses
186.87
0
186.87
Other Expenses
4.41
0.00
4.41
Total Expenditure (Excl Depreciation)
726.36
0
726.36
Operating Profit (PBDIT) excl Other Income
110.38
0.00
110.38
Other Income
29.09
0
29.09
Operating Profit (PBDIT)
134.11
0
134.11
Interest
8.85
0
8.85
Exceptional Items
1.20
0
1.20
Gross Profit (PBDT)
350.25
0
350.25
Depreciation
0.00
0
0.00
Profit Before Tax
126.46
0
126.46
Tax
10.27
0
10.27
Provisions and contingencies
0
0
0.00
Profit After Tax
105.78
0
105.78
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
105.78
0
105.78
Share in Profit of Associates
0
0
0.00
Minority Interest
12.94
0
12.94
Other related items
0.00
0.00
0.00
Consolidated Net Profit
118.73
0
118.73
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
4,673.16
0
4,673.16
Earnings per share (EPS)
0.23
0
0.23
Diluted Earnings per share
0.23
0
0.23
Operating Profit Margin (Excl OI)
12.55%
0%
0.00
12.55%
Gross Profit Margin
15.11%
0%
0.00
15.11%
PAT Margin
12.64%
0%
0.00
12.64%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 83.67 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is -5.56% vs 8.61% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 1.43% vs 39.08% in Sep 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 11.87 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is -21.91% vs 26.56% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 20.51% vs -2.86% in Sep 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 10.50 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is -41.86% vs 4.70% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is -6.83% vs -15.07% in Sep 2024

Quarterly - Interest
Interest 0.89 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is -3.26% vs 0.00% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 0.00% vs 48.33% in Sep 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 12.55%
in Sep 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024